· rebuilt nightly from public records
Signal Sheet
Headquartered in Cambridge, Massachusetts, Ernexa Therapeutics is a publicly listed pharmaceutical preparations company. It raised $7.2M in Mar 2025 and its filings name 6 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Sandra Gurrola | SEC filing, Mar 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Sanjeev Luther | SEC filing, Mar 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | James Bristol | SEC filing, Mar 2025 | Technology and tooling decisions |
| Chief Technology Officer | Peter Cicala | SEC filing, Mar 2025 | Technology and tooling decisions |
| Chief Technology Officer | Elena Ratner | SEC filing, Mar 2025 | Technology and tooling decisions |
| Chief Technology Officer | William Wexler | SEC filing, Mar 2025 | Technology and tooling decisions |
Officer or director change
New leadershipEquity raise reported to the SEC, Mar 2025. Money arrives before the spending plan does.
CapitalEach with a title and the filing that names them, so the first call goes to the right desk.
PeopleThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Sep 14, 2026 | Officer or director change | New leadership | SEC filing |
| Mar 31, 2025 | Raised $7.2M in equity from 15 investors | Capital | SEC filing |
[email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.Lakewave finds the right people at Ernexa Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Ernexa Therapeutics with a free trial →| Headquarters | Cambridge, Massachusetts, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Ownership | Listed company |
| Raise history | $7.2M (Mar 2025) |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Ernexa Therapeutics reported a $7.2M equity raise to the SEC on Mar 31, 2025 with 15 investors.
The company's SEC filing, Mar 2025 names Sandra Gurrola (Executive Officer) among its officers.
Cambridge, Massachusetts, per the address on its SEC filing.
Ernexa Therapeutics uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.
Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.